Central Retinal Vein Occlusion Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight
Central retinal vein occlusion, also known as CRVO, is a condition in which the main vein that drains blood from the retina closes off partially or completely. This can cause blurred vision and other problems with the eye.
DelveInsight's "Central
Retinal Vein Occlusion Market Insights, Epidemiology, and
Market Forecast-2030" report delivers an in-depth understanding
of the Central Retinal Vein Occlusion, historical and forecasted epidemiology
as well as the Central Retinal Vein Occlusion market trends in the United
States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some Key Highlights from the Central
Retinal Vein Occlusion Market Report:
·
In the 7MM, the total diagnosed cases of
Retinal Vein Occlusion by age distribution were 1,166,736, 535,472, and 318,025
cases for the age group less than 65 years, 65-74 years, and ≥75 years, in
2020.
·
According to
DelveInsight, the majority of cases of Retinal Vein Occlusion are found in
females as compared to males.
·
In the 7MM,
Central retinal vein occlusion contributed to 407,058 cases in 2020. Furthermore,
in 2020, there were around 1,613,175 BRVO cases.
·
US has the
highest percentage of prevalent, diagnosed and treated patients.
·
The Retinal Vein
Occlusion Market size was found to be USD 2,328 Million in 2020 in 7MM.
View Report: https://www.delveinsight.com/report-store/central-retinal-vein-occlusion-market
Request for Sample Report @ https://www.delveinsight.com/sample-report/central-retinal-vein-occlusion-market
Mild Central
retinal vein occlusion may show no
symptoms. However:
- Many
patients with Central retinal vein
occlusion have symptoms such as blurry or distorted vision due to
swelling of the center part of the retina, known as the macula.
- Some
patients have mild symptoms that wax and wane, called transient
visual obscurations.
- Patients
with severe Central retinal vein occlusion and secondary complications
such as glaucoma (a disease characterized by increased
pressure in the eye) often have pain, redness, irritation and other problems.
View Report: https://www.delveinsight.com/report-store/central-retinal-vein-occlusion-market
Request for Sample Report @ https://www.delveinsight.com/sample-report/central-retinal-vein-occlusion-market
Some of the Central
Retinal Vein Occlusion Companies:
·
Regeneron
Pharmaceuticals
·
Bayer
·
The Emmes
Company, LLC
·
Novartis
·
Genentech, Inc
·
Bausch & Lomb
·
And Many More
View Report: https://www.delveinsight.com/report-store/central-retinal-vein-occlusion-market
Request for Sample Report @ https://www.delveinsight.com/sample-report/central-retinal-vein-occlusion-market
Central
Retinal Vein Occlusion Pipeline Therapies:
- Sham
- Brolucizumab
- Aflibercept
- Bevacizumab
- Aflibercept
- BAY86-5321
- Ranibizumab
- And Many Others
Table of Contents
1. |
Report Introduction |
2. |
Executive Summary of Central Retinal
Vein Occlusion |
3. |
Central Retinal Vein Occlusion
Market Overview at a Glance |
4. |
Disease Background and Overview: Central
Retinal Vein Occlusion |
5. |
Case Reports of Central Retinal Vein
Occlusion |
6. |
Central Retinal Vein Occlusion
Patient Journey |
7. |
Central Retinal Vein Occlusion
Epidemiology and Patient Population |
8. |
Epidemiology of Central Retinal Vein
Occlusion by Countries (2018–2030) |
9. |
Central Retinal Vein Occlusion
Treatments and Medical Practices |
10. |
Central Retinal Vein Occlusion
Marketed Therapies |
11. |
Central Retinal Vein Occlusion
Emerging Therapies |
12. |
Central Retinal Vein Occlusion
Market Size |
13. |
7MM: Country-wise Market Analysis |
14. |
Central Retinal Vein Occlusion
Market Drivers |
15. |
Central Retinal Vein Occlusion
Market Barriers |
16. |
SWOT Analysis |
17. |
KOL Views |
18. |
Reimbursement and market access |
19. |
Report Methodology |
20. |
DelveInsight Capabilities |
21. |
Disclaimer |
22. |
About DelveInsight |
About DelveInsight
DelveInsight is a leading Business
Consultant and Market Research firm focused exclusively on life sciences. It
supports Pharma companies by providing end to end comprehensive solutions to
improve their performance.
Central Retinal Vein Occlusion market,Central
Retinal Vein Occlusion market trends,Central Retinal Vein Occlusion market
forecast,Central Retinal Vein Occlusion market share,Central Retinal Vein
Occlusion pipeline,Central Retinal Vein Occlusion treatment algorithm,Central
Retinal Vein Occlusion drugs,Central Retinal Vein Occlusion market size,Central
Retinal Vein Occlusion CAGR,Central Retinal Vein Occlusion epidemiology
Comments
Post a Comment